Blueprint Medicines Corporation
BPMC | NASDAQ
$129.46
+$0.18 (+0.14%)
At close: Jul 18, 2025, 04:00 PM ET
0.14%
(1Y)Rating
Updated: Sep 22, 2026Key Statistics
Market Data
Market Cap $8.36B
1D Range
129.46 129.46
52W Range
73.04 129.55
Valuation (TTM)
PE -52.41
PB 24.44
EV/EBITDA -60.34
Valuation (NTM)
Forward PE 35.10
Forward PEG -0.41
Price Target $113.07
Cash Flow
FCF Yield -1.8%
SBC Adj. FCF Yield -3.2%
SBC Impact -75.4%
Margins
Gross Margin 96.0%
Operating Margin -31.0%
FCF Margin -26.9%
Growth (CAGR)
Revenue 3Y | 5Y 36.5% |
50.9%
Dil EPS 3Y | 5Y 63.9% |
-22.2%
FCF 3Y | 5Y 48.7% |
-35.1%
Returns
ROA -5.7%
ROE -31.3%
ROIC -21.7%
Financial Health
Net Cash
$453.49M
Current Ratio 2.85
Interest Coverage -3.08
Dividends
Div Yield N/A
Payout Ratio N/A
FCF Payout Ratio N/A
Loading financial charts...
Profile
A detailed description of the company is not yet available.
Latest News
No news articles available yet.
Add to Watchlist
Select watchlists to add or remove BPMC